Clinical Trial Update: Local Paclitaxel Delivery for SFA Disease [NA]

View source ↗

Summary

The University of Oklahoma reports that a clinical trial evaluating local paclitaxel delivery for superficial femoral artery disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Peripheral Arterial Disease

Drugs mentioned

• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: University of Oklahoma | Conditions: Atherosclerosis, Angioplasty | NA | Status: COMPLETED